The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Its new guidance would trade the clarity and reach of our current strategy for a confusing framework that simply doesn’t fit reality.

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

The first group of about 900 12-week-old ducks were transported to the duck farm early Monday morning, a week after a USDA ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

University of Pennsylvania researchers have discovered a right-handed, antiparallel double-helix inside influenza ...